ResearcherCity of HopeNo recent work listed

Stephen I. Shibata

Verified by OpenAlex author ID (good confidence)As of 15 November 2026

Matched on OpenAlex author ID A5027495771.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers: 1
Pancreatic cancer trials: 1
Pancreatic cancer grants: 0
Collaborators: 3

Papers, trials and grants by year

1997: 1 trial · 1998: none · 1999: none · 2000: none · 2001: none · 2002: none · 2003: none · 2004: none · 2005: none · 2006: none · 2007: none · 2008: none · 2009: none · 2010: none · 2011: none · 2012: 1 paper

Papers 1

A randomized phase II of gemcitabine and sorafenib versus sorafenib alone in patients with metastatic pancreatic cancer. Co-author DOI 10.1007/s10637-011-9658-9 ↗

Trials 1

Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer Study chair NCT00544193 ↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Heinz-Josef Lenz · 1 shared paper, 2012
- Paper A randomized phase II of gemcitabine and sorafenib versus sorafenib alone in patients with metastatic pancreatic cancer. DOI 10.1007/s10637-011-9658-9 ↗
Ramesh K. Ramanathan · 1 shared paper, 2012
- Paper A randomized phase II of gemcitabine and sorafenib versus sorafenib alone in patients with metastatic pancreatic cancer. DOI 10.1007/s10637-011-9658-9 ↗
Anthony B. El-Khoueiry · 1 shared paper, 2012
- Paper A randomized phase II of gemcitabine and sorafenib versus sorafenib alone in patients with metastatic pancreatic cancer. DOI 10.1007/s10637-011-9658-9 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.